Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Maybe Autism drug?
Maybe the agreement is a first step on the way of setting up another trial in combination with Neupogen. As far as I know we haven't been bought out yet so its wise to explore formulations that make sense for the patient and shareholders ;)
Oddone, it drops because of maker's manipulation. It's the shady and foul underbelly in OTC. They and their cronies create $ and opportunity for those in the know and all we can do is sit back and watch.
This is all behind the scene manipulation. The "makers" are doing their thing. They are having a blast and making themselves and their cronies filthy rich. One minute at a time, one day at a time. It's disgusting how they hook others up so they make a killing on the way up and on the way down.
Yup! Also, this manipulation is at a very low PPS so if that's what it takes for them to pay their bills, well so be it. They won't have deep enough pockets by year's end to affect anything and there will be a great deal of confidence in CTIX so all emotions will be taken off the table.
I don't think we have any problems with dilution or shaky management so sit back and enjoy the ride :)
How long do we have to be at $3 before we can uplist? That's when the real pressure to increase PPS will come :)
Contrary to popular belief, a cure will fill your pockets. First off, a cure does not prevent anything so there are new patients diagnosed every day. Second all these other b@ll sh;t modalities if treatment will be obsolete therefore K would cash in by replacing surgeries, radio therapy, chemo combos, holistic therapies etc. Basically, people would pay even more for a cure than a treatment. The demand would GE un precedented. Third and most importantly, compared to chronic diseases, cancer patients do not live as long so trying to milk them till their the last breath isn't worthwhile.
Ladies and gentlemen, its Saturday afternoon. If you are just bored go on one of those social networking sites because its a long way till Tuesday. If by chance you have verifiable information to add then please do :).
The mouse studies are more telling while the dog studies are almost a waste of time because they have no real correlation to a "would be" human response.
How many days notice must be given to shareholders in the case of a tender offer?
Please slow your roll everyone, I'm still accumulating. ;)
Sweet! I'm still traveling so this level if detail is greatly appreciated :)
I'm on the road so I can't look I to this but someone picked up shares at 1.75... What gives???
Thanks! Tons of info!
Thanks! I wouldn't have expected this for a drug with such potential. You would think that they would want statistics that were beyond scrutiny.
They don't know what they are receiving (placebo, drug etc.) or dose and its exact mechanisms in order to not skew results.
Has anyone done any due diligence on the other drugs that CTIX is working on?
Indeed.
Cancerous cells consume more energy than non cancerous cells because they are growing and dividing without regulation so many pharmaceuticals are combined with glucose to create this affinity and to deliver the majority of the drug to the cancerous cells.
Lets not go there, "incubus-now".
I stand behind my assessment but i also hope to be proven wrong and hope to be wealthy sooner rather than later.
Per the FDA link that KarinCA posted, the Kevetrin Phase I study is estimated to be complete April 2014 with the final data collection to be completed by October 2013. For this reason I do not expect any firm press releases or major upward PPS increases till next year UNLESS Purisol gets wrapped up and is deliverable this year. My two cents.
How long before the PPS goes above the $2-3 range?
I'm not very experienced but a buy out seems very likely because a larger company can easily bring a novel product to market while a new upstart has yet to produce revenue and therefore lacks the necessary working Capitol to see a product all the way through to market. If my gut instinct is correct, has anyone tried to assess a range for possible buy out share price??? Obviously this is all speculative but I'm curious to know since you have all done a great deal of DD. THANKS in advance!
Thanks!!!!
When did this board come to be and how long has there been a CTIX following?